FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807888670> ?p ?o ?g. }

• W2807888670 endingPage "1288" @default.
• W2807888670 startingPage "1285" @default.
• W2807888670 abstract "The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend that T-cell–depleting agents should be used only for kidney transplant (KT) recipients at high immunologic risk. However, the effects of thymoglobulin induction therapy in low–immunologic risk KT recipients on tacrolimus, mycophenolic acid, and steroid have not been elucidated yet. We retrospectively collected 6 months postoperative clinical data, for low–immunologic risk KT recipients at Soonchunhyang University Hospital. Recipients were divided into thymoglobulin and basiliximab groups, based on the induction agent used. Low–immunologic risk recipients were defined as those with panel-reactive antibody level <30% at the time of kidney transplantation. The incidence of biopsy-proven acute rejection and borderline change was compared between the two groups. Of the 46 low–immunologic risk patients, 25 received thymoglobulin. The incidence of biopsy-proven acute rejection was 0% (n = 0) and that of borderline change was 8% (n = 2) in the thymoglobulin group. The basiliximab group had a significantly higher incidence of rejection (23.8%; n = 5; P = .015) and borderline change (42.9%; n = 9; P = .006). No significant difference in estimated glomerular filtration rate was found between the two groups at 6 months after kidney transplantation. Cytomegalovirus (CMV) infection occurred more frequently in the thymoglobulin group than in the basiliximab group. All patients with CMV infection in both groups were effectively treated with pre-emptive intravenous ganciclovir therapy. In low–immunologic risk KT recipients who received tacrolimus, mycophenolic acid, and steroid therapy, thymoglobulin induction therapy significantly reduced the incidence of biopsy-proven acute rejection and borderline change compared with basiliximab induction therapy." @default.
• W2807888670 created "2018-06-21" @default.
• W2807888670 creator A5012190757 @default.
• W2807888670 creator A5025168962 @default.
• W2807888670 creator A5036109427 @default.
• W2807888670 creator A5048677850 @default.
• W2807888670 creator A5050814795 @default.
• W2807888670 creator A5056985822 @default.
• W2807888670 creator A5068691702 @default.
• W2807888670 creator A5086714791 @default.
• W2807888670 date "2018-06-01" @default.
• W2807888670 modified "2023-10-01" @default.
• W2807888670 title "Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience" @default.
• W2807888670 cites W1976474080 @default.
• W2807888670 cites W1992967149 @default.
• W2807888670 cites W2000531481 @default.
• W2807888670 cites W2033506916 @default.
• W2807888670 cites W2043309772 @default.
• W2807888670 cites W2072651170 @default.
• W2807888670 cites W2087632980 @default.
• W2807888670 cites W2135136335 @default.
• W2807888670 cites W2170783570 @default.
• W2807888670 cites W2398267064 @default.
• W2807888670 cites W2553399010 @default.
• W2807888670 cites W2604771942 @default.
• W2807888670 doi "https://doi.org/10.1016/j.transproceed.2018.02.088" @default.
• W2807888670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29880348" @default.
• W2807888670 hasPublicationYear "2018" @default.
• W2807888670 type Work @default.
• W2807888670 sameAs 2807888670 @default.
• W2807888670 citedByCount "9" @default.
• W2807888670 countsByYear W28078886702019 @default.
• W2807888670 countsByYear W28078886702020 @default.
• W2807888670 countsByYear W28078886702021 @default.
• W2807888670 countsByYear W28078886702022 @default.
• W2807888670 countsByYear W28078886702023 @default.
• W2807888670 crossrefType "journal-article" @default.
• W2807888670 hasAuthorship W2807888670A5012190757 @default.
• W2807888670 hasAuthorship W2807888670A5025168962 @default.
• W2807888670 hasAuthorship W2807888670A5036109427 @default.
• W2807888670 hasAuthorship W2807888670A5048677850 @default.
• W2807888670 hasAuthorship W2807888670A5050814795 @default.
• W2807888670 hasAuthorship W2807888670A5056985822 @default.
• W2807888670 hasAuthorship W2807888670A5068691702 @default.
• W2807888670 hasAuthorship W2807888670A5086714791 @default.
• W2807888670 hasConcept C120665830 @default.
• W2807888670 hasConcept C121332964 @default.
• W2807888670 hasConcept C126322002 @default.
• W2807888670 hasConcept C141071460 @default.
• W2807888670 hasConcept C203014093 @default.
• W2807888670 hasConcept C2522874641 @default.
• W2807888670 hasConcept C2776317777 @default.
• W2807888670 hasConcept C2777630719 @default.
• W2807888670 hasConcept C2777965375 @default.
• W2807888670 hasConcept C2779015954 @default.
• W2807888670 hasConcept C2779820661 @default.
• W2807888670 hasConcept C2780073493 @default.
• W2807888670 hasConcept C2780252810 @default.
• W2807888670 hasConcept C2780303639 @default.
• W2807888670 hasConcept C2781307858 @default.
• W2807888670 hasConcept C2909675724 @default.
• W2807888670 hasConcept C2911091166 @default.
• W2807888670 hasConcept C61511704 @default.
• W2807888670 hasConcept C64518967 @default.
• W2807888670 hasConcept C71924100 @default.
• W2807888670 hasConcept C90924648 @default.
• W2807888670 hasConceptScore W2807888670C120665830 @default.
• W2807888670 hasConceptScore W2807888670C121332964 @default.
• W2807888670 hasConceptScore W2807888670C126322002 @default.
• W2807888670 hasConceptScore W2807888670C141071460 @default.
• W2807888670 hasConceptScore W2807888670C203014093 @default.
• W2807888670 hasConceptScore W2807888670C2522874641 @default.
• W2807888670 hasConceptScore W2807888670C2776317777 @default.
• W2807888670 hasConceptScore W2807888670C2777630719 @default.
• W2807888670 hasConceptScore W2807888670C2777965375 @default.
• W2807888670 hasConceptScore W2807888670C2779015954 @default.
• W2807888670 hasConceptScore W2807888670C2779820661 @default.
• W2807888670 hasConceptScore W2807888670C2780073493 @default.
• W2807888670 hasConceptScore W2807888670C2780252810 @default.
• W2807888670 hasConceptScore W2807888670C2780303639 @default.
• W2807888670 hasConceptScore W2807888670C2781307858 @default.
• W2807888670 hasConceptScore W2807888670C2909675724 @default.
• W2807888670 hasConceptScore W2807888670C2911091166 @default.
• W2807888670 hasConceptScore W2807888670C61511704 @default.
• W2807888670 hasConceptScore W2807888670C64518967 @default.
• W2807888670 hasConceptScore W2807888670C71924100 @default.
• W2807888670 hasConceptScore W2807888670C90924648 @default.
• W2807888670 hasIssue "5" @default.
• W2807888670 hasLocation W28078886701 @default.
• W2807888670 hasLocation W28078886702 @default.
• W2807888670 hasOpenAccess W2807888670 @default.
• W2807888670 hasPrimaryLocation W28078886701 @default.
• W2807888670 hasRelatedWork W1966299088 @default.
• W2807888670 hasRelatedWork W1967915560 @default.
• W2807888670 hasRelatedWork W1968059227 @default.
• W2807888670 hasRelatedWork W2040527261 @default.
• W2807888670 hasRelatedWork W2065729608 @default.
• W2807888670 hasRelatedWork W2417597819 @default.

• next